
Established on March 19, 1992, the Nuveen Select Tax-Free Income Portfolio functions as a closed-ended mutual fund dedicated to fixed income investments within the United States. Jointly overseen by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC (under the Nuveen Investments Inc. umbrella), the fund strategically allocates its capital primarily to investment-grade municipal securities, targeting those rated Baa, BBB, or higher. Its financial performance is benchmarked against both the Standard & Poor's (S&P) National Municipal Bond Index and the Lipper General and Insured Unleveraged Municipal Debt Funds Average. This portfolio remains domiciled in the U.S.
Is NXP's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
EINDHOVEN, The Netherlands, Oct. 06, 2026 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it will release financial results for the third quarter 2026 after the close of normal trading on the NASDAQ Global Select Market on Tuesday, October 27, 2026.

Nuveen Sl Tfip (NYSE: NXP - Get Free Report)'s stock price reached a new 52-week low on Monday. The stock traded as low as $12.90 and last traded at $12.90, with a volume of 155866 shares traded. The stock had previously closed at $13.06. Nuveen Sl Tfip Stock Performance The stock's 50 day simple moving average

Fort Lee, NJ, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, announced today that NXP200 (HSK42360), an oral, brain-penetrant, paradox-breaker BRAF inhibitor, has been granted Breakthrough Therapy Designation (BTD) for the treatment of patients with BRAF V600-mutant, recurrent or progressive high-grade glioma by China's Center for Drug Evaluation (CDE).
The transaction involved 1,000 shares executed at $226.04 per share. The sale represented 11% of the direct equity stake held prior to the filing.
NXP Semiconductors NASDAQ: NXPI is positioning its portfolio around “physical AI,” with Chief Executive Officer Rafael Sotomayor saying the company aims to apply its longstanding strengths in security, functional safety, real-time processing and reliability to increasingly intelligent edge devices.